Drug Profile
FE 204205
Alternative Names: FE-204205Latest Information Update: 28 Dec 2019
Price :
$50
*
At a glance
- Originator Ferring Pharmaceuticals
- Class
- Mechanism of Action Vasopressin 1a receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Ascites; Portal hypertension
Most Recent Events
- 28 Dec 2019 No recent reports of development identified for phase-I development in Portal-hypertension in Spain (IV, Infusion)
- 28 Sep 2018 No recent reports of development identified for phase-I development in Ascites in Unknown (Parenteral)
- 27 Sep 2017 Ferring Pharmaceuticals terminates a phase I trial in Portal hypertension in Spain due to difficult recruitment (IV)(NCT02929407)